Myth: Alternative nicotine products don't help people stop smoking: Difference between revisions

Jump to navigation Jump to search
Line 272: Line 272:
<br>
<br>


='''Using Alternative Nicotine Products by People Living With Mental Health Challenges to Aid Smoking Cessation'''=
='''Using Alternative Nicotine Products by People Living With ''Physical Health Challenges'' to Aid Smoking Cessation'''=
 
===2022: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908735/ Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): A Feasibility Trial of Nicotine Vaping Products for Smoking Cessation Among People Living with HIV]===
*This study found that the provision of NVPs for 12 weeks was associated with 7-day point prevalence tobacco smoking abstinence among 35% of a sample of PLHIV who smoked tobacco daily. These findings suggest that NVPs represent a potentially feasible and effective short-to-medium term tobacco smoking cessation aid and/or tobacco harm reduction strategy among PLHIV.
<br>
 
='''Using Alternative Nicotine Products by People Living With ''Mental Health Challenges'' to Aid Smoking Cessation'''=


===2021: [https://academic.oup.com/ntr/article/23/7/1113/6168972 A Single-Arm, Open-Label, Pilot, and Feasibility Study of a High Nicotine Strength E-Cigarette Intervention for Smoking Cessation or Reduction for People With Schizophrenia Spectrum Disorders Who Smoke Cigarettes]===
===2021: [https://academic.oup.com/ntr/article/23/7/1113/6168972 A Single-Arm, Open-Label, Pilot, and Feasibility Study of a High Nicotine Strength E-Cigarette Intervention for Smoking Cessation or Reduction for People With Schizophrenia Spectrum Disorders Who Smoke Cigarettes]===
Line 280: Line 286:
*A high strength nicotine e-cigarette has the potential to help people with schizophrenia spectrum disorders to quit or reduce smoking.
*A high strength nicotine e-cigarette has the potential to help people with schizophrenia spectrum disorders to quit or reduce smoking.
*[https://scholar.google.com/scholar_url?url=https://academic.oup.com/ntr/article-pdf/23/7/1113/38521536/ntab005.pdf&hl=en&sa=T&oi=ucasa&ct=ufr&ei=yBQBYYa-NZHsyQTPkaSoDg&scisig=AAGBfm3GpEvV3isL4-eiS-xFao9KegDu2Q PDF Version]
*[https://scholar.google.com/scholar_url?url=https://academic.oup.com/ntr/article-pdf/23/7/1113/38521536/ntab005.pdf&hl=en&sa=T&oi=ucasa&ct=ufr&ei=yBQBYYa-NZHsyQTPkaSoDg&scisig=AAGBfm3GpEvV3isL4-eiS-xFao9KegDu2Q PDF Version]
*Citation: Pasquale Caponnetto, PhD, Jennifer DiPiazza, PhD, Jason Kim, MD, Marilena Maglia, Lyc Psych, Riccardo Polosa, MD, PhD, A Single-Arm, Open-Label, Pilot, and Feasibility Study of a High Nicotine Strength E-Cigarette Intervention for Smoking Cessation or Reduction for People With Schizophrenia Spectrum Disorders Who Smoke Cigarettes, Nicotine & Tobacco Research, Volume 23, Issue 7, July 2021, Pages 1113–1122, doi:10.1093/ntr/ntab005
*Acknowledgement: The authors wish also to thank PAX Labs (on June 13, 2017 the company became known as JUUL Labs) for the free supplies of JUUL e-cigarette kits and pods. At the time the research was conducted JUUL Labs were not part owned by Altria, a tobacco company. PAX Labs agreed also to supply pods for a further 3 months after the end of the pilot to participants who expressed a wish to continue using as JUUL was not available in Italy when this study has been conducted and not currently available at the 5% nicotine strength.
<br>
<br>